The FDA is reviewing a possible link between the asthma drug Xolair and an increased risk of heart and cerebrovascular disorders.Since the FDA investigation is still under way, the agency is not telling doctors to stop prescribing Xolair and is not recommending any changes to the prescribing information for Xolair.
More...
When abortion restrictions are in the news, as they have been for several weeks, research shows...
Yet another item that may be in your pantry has been recalled over possible salmonella contamination.
A...
By the time the American surgeon who contracted Ebola in Congo was flown to Germany for...
The Trump administration has announced a plan to kill Biden-era drinking water limits on four Pfas...
